Degarelix for treating advanced hormone‐sensitive prostate cancer

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of degarelix compared with standard systemic androgen suppression therapy (in the form of surgical castration, medical castration using GnRH agonists, non‐steroidal or steroidal antiandrogen...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cochrane Database Syst Rev
Egile Nagusiak: Jakob, Joachim J, Schmidt, Stefanie, Kunath, Frank, Meerpohl, Joerg J, Blümle, Anette, Schmucker, Christine, Mayer, Benjamin, Zengerling, Friedemann
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley & Sons, Ltd 2017
Gaiak:
Medicine General & Introductory Medical Sciences
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6464394/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012548
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak